News Tagged ‘Bayer Schering Pharma

Judge orders birth control pill makers to turn over files for litigation

District Judge David Herndon is ordering sales representatives who pushed the oral contraceptives Yasmin, Yaz, Ocella and Gianvi to produce all their files and communications for national litigation. The order covers “all written materials, video and/or audio tapes” and includes training materials, e-mails, voice mail transcripts, summaries of meetings, incentive and goal plans, and all communications between representatives and managers. Herndon also ordered Bayer Health Care Pharmaceuticals, Bayer Schering Pharma, Barr Laboratories, and Teva Pharmaceuticals to produce records from their facilities.

Read the rest of this entry »

Yasmin birth control pill to receive label changes

yasmin 100x100 Yasmin birth control pill to receive label changesBayer Schering Pharma has announced it will update the label in the European market for its oral contraceptive Yasmin, a combination of ethinylestradiol and the diuretic drospirenone, also known by the brand name Yaz and the generic brand Ocella. The new label will include results of four epidemiological studies conducted by independent investigators that show the risk for venous thromboembolism, or blood clots, in Yasmin users is comparable to the risk found for women who use levonorgestrel-containing oral contraceptives.

Read the rest of this entry »